ALPK1 and macular retinal edema: Her diagnostic odyssey culminated at 15YO with the identification of the pathogenic variant p.Tyr254Cys in ALPK1. Recently, tocilizumab, an IL-6 receptor antagonist, was added, resulting in significant reduction in macular edema and optic disc swelling just within one month.